Erica Tsang (@ericatsangmd) 's Twitter Profile
Erica Tsang

@ericatsangmd

GI medical oncologist @pmcancercentre @uoftmedicine s/p @UCSFCancer @BCCancer | @AACR AMC #GICancer Tweets are my own, RT not endorsements.

ID: 1081263058989735937

calendar_today04-01-2019 18:56:16

79 Tweet

331 Followers

354 Following

Cancer Research Communications (@crc_aacr) 's Twitter Profile Photo

Just published! A phase Ib trial of the PI3K inhibitor alpelisib and weekly cisplatin in patients with solid tumor malignancies. Read more in this study by Erica Tsang et al. bit.ly/3O6jsrU UC San Francisco #openaccess

Just published! A phase Ib trial of the PI3K inhibitor alpelisib and weekly cisplatin in patients with solid tumor malignancies. Read more in this study by <a href="/EricaTsangMD/">Erica Tsang</a> et al.
bit.ly/3O6jsrU
<a href="/UCSF/">UC San Francisco</a> #openaccess
WinC - AlinC (Women in Cancer - All in Cancer) (@women_in_cancer) 's Twitter Profile Photo

Happy International Women’s Day! Come join us Women-in-Cancer for our new series “Strengthening through Perspectives” and engage with our growing international community! Register at womenincancer.com Christine Simmons Christine Brezden Hina Saeed, MD Ishwaria Subbiah, MD MS FASCO Belinda Campbell

Happy International Women’s Day! Come join us Women-in-Cancer for our new series “Strengthening through Perspectives” and engage with our growing international community! Register at womenincancer.com <a href="/DrCESimmons/">Christine Simmons</a> <a href="/DrCBrezden/">Christine Brezden</a> <a href="/HinaSaeedMD/">Hina Saeed, MD</a> <a href="/IshwariaMD/">Ishwaria Subbiah, MD MS FASCO</a> <a href="/belinda_campbe/">Belinda Campbell</a>
Sharlene Gill, MD, MPH, MBA, FASCO (@gillsharlene) 's Twitter Profile Photo

Thank you WinC - AlinC (Women in Cancer - All in Cancer) - Women in Cancer / All in Cancer for the Keynote invitation 🙏 ➡️ Strengthening through Perspectives 🗓️ Friday April 28th at 530pm EST Faculty Club, University of Toronto Join us 👉Register at womenincancer.com #HappyInternationalWomensDay

Thank you <a href="/women_in_cancer/">WinC - AlinC (Women in Cancer - All in Cancer)</a> - Women in Cancer / All in Cancer for the Keynote invitation 🙏 

➡️ Strengthening through Perspectives
🗓️ Friday April 28th at 530pm EST
Faculty Club, University of Toronto

Join us 👉Register at womenincancer.com

#HappyInternationalWomensDay
Francesco Caiazza (@francescocay) 's Twitter Profile Photo

I had the best of times hearing about the research projects presented in the undergraduate student caucus and poster competition. So much enthusiasm and talent packed in a room! Thank you to the #AACRAMC judges @KristinAltwegg @waynerlawrence Mathias Seviiri, MD, MPH, PhD Safa

I had the best of times hearing about the research projects presented in the undergraduate student caucus and poster competition. So much enthusiasm and talent packed in a room! Thank you to the #AACRAMC judges @KristinAltwegg @waynerlawrence <a href="/MathiasSeviiri/">Mathias Seviiri, MD, MPH, PhD</a> <a href="/safamajeed/">Safa</a>
Katie Campbell (@campkatiee) 's Twitter Profile Photo

A great opportunity to support the next generation of cancer research AACR the Undergraduate Student Poster Competition is open until 4PM #AACR23 #AACRGlobalScholars

Grainne O'Kane (@graokane) 's Twitter Profile Photo

Always a treat to hear Anirban Maitra describe RAS signalling and differences in KRAS mutant alleles in #PancreaticCancer pathogenesis ➡️ integration of transcriptomics to interrogate TME and metabolomics #abstract4020 ✅ Differences certainly in G12D vs G12R

Always a treat to hear <a href="/Aiims1742/">Anirban Maitra</a> describe RAS signalling and differences in KRAS mutant alleles  in #PancreaticCancer pathogenesis
➡️ integration of transcriptomics to interrogate TME and metabolomics #abstract4020
✅ Differences certainly in G12D vs G12R
Grainne O'Kane (@graokane) 's Twitter Profile Photo

RMC-6236 RAS-MULTI (ON) inhibitor ➡️promising activity in heavily pre-treated PDAC pts ➡️ORR 20% in 46 pts ➡️median time to response 1.4mths ➡️median time on tx 3.3 mths ✅ctDNA clearance >50% in 92% ➡️likely to need combinations but +exciting for PDAC #ESMO23 #PancreaticCancer

RMC-6236 RAS-MULTI (ON) inhibitor
➡️promising activity in heavily pre-treated PDAC pts
➡️ORR 20% in 46 pts 
➡️median time to response 1.4mths
➡️median time on tx 3.3 mths
✅ctDNA clearance &gt;50% in 92%
➡️likely to need combinations but +exciting for PDAC #ESMO23 #PancreaticCancer
Grainne O'Kane (@graokane) 's Twitter Profile Photo

PREOPANC-2 ➡️FFX vs Gemrads in resectable/ early BR #PancreaticCancer ➡️no diff in resection rates/OS/toxicity ❓recurrence patterns ➡️Nb full dose FFX #ESMO23

PREOPANC-2 
➡️FFX vs Gemrads in resectable/ 
early BR #PancreaticCancer
➡️no diff in resection rates/OS/toxicity
❓recurrence patterns 
➡️Nb full dose FFX 
#ESMO23
Lillian Siu (@lillian_siu) 's Twitter Profile Photo

Princess Margaret Cancer Centre looking forward to Cancer Genomics - Tumor Immunotherapy Program Annual Symposium on Friday Nov 10 in MaRS auditorium. Amazing line up of speakers 👏🔥 pm-genomics-IO-symposium.ca

<a href="/pmcancercentre/">Princess Margaret Cancer Centre</a> looking forward to Cancer Genomics - Tumor Immunotherapy Program Annual Symposium on Friday Nov 10 in MaRS auditorium. Amazing line up of speakers 👏🔥 pm-genomics-IO-symposium.ca
Marathon of Hope Cancer Centres Network (@marathonofhope) 's Twitter Profile Photo

🍁 MAESTRO: A Pan-Canadian project to accelerate #precisionmedicine for #pancreaticcancer🍁 🩺 Sadly, #PancreaticCancer is one of the deadliest cancers 🩺 Today, patients have very few treatment options, and those that exist are often ineffective

🍁 MAESTRO: A Pan-Canadian project to accelerate #precisionmedicine for #pancreaticcancer🍁

🩺 Sadly, #PancreaticCancer is one of the deadliest cancers

🩺 Today, patients have very few treatment options, and those that exist are often ineffective
MunsterLab UCSF (@munsterlab1) 's Twitter Profile Photo

A special evening today: Dr. Pamela Munster gets endowed with Mariam Moghadam Safinia distinguished professorship in hereditary cancer research UCSF Helen Diller Family Comprehensive Cancer Ctr #breastcancer #Oncology #researchers

A special evening today: Dr. Pamela Munster gets endowed with Mariam Moghadam Safinia distinguished professorship in hereditary cancer research
<a href="/UCSFCancer/">UCSF Helen Diller Family Comprehensive Cancer Ctr</a> #breastcancer #Oncology #researchers
Grainne O'Kane (@graokane) 's Twitter Profile Photo

PASS-01 trial #PDAC #ASCO24 ➡️rand ph2 mFFX vs.GnP ➡️WGS/RNA/PDO/CTCs/ctDNA ✅PP PFS 5.5 (GnP) vs. 4.0mths (mFFX) ➡️PP ❌gBRCA/PALB2 >KRASWT in GnP ➡️MTB directed 2nd line ➡️ GnP remains a backbone for drug dvp ➡️basal-like unmet need Proud Dr. Amber Habowski as translational leads

PASS-01 trial #PDAC #ASCO24 
➡️rand ph2 mFFX vs.GnP
➡️WGS/RNA/PDO/CTCs/ctDNA
✅PP PFS 5.5 (GnP) vs. 4.0mths (mFFX)
➡️PP ❌gBRCA/PALB2 &gt;KRASWT in GnP
➡️MTB directed 2nd line
➡️ GnP remains a backbone for drug dvp
➡️basal-like unmet need
Proud <a href="/AmberHabowski/">Dr. Amber Habowski</a> as translational leads
Marathon of Hope Cancer Centres Network (@marathonofhope) 's Twitter Profile Photo

💬 "I’m glad my data will play a role in bringing hope to more cancer patients" 💬 Precision oncology has given Dan Murphy new hope. Now, he's sharing his story – and his data – to bring that hope to other patients. 🍁  Full story ▶ bit.ly/47Vmw4U

💬 "I’m glad my data will play a role in bringing hope to more cancer patients" 💬

Precision oncology has given Dan Murphy new hope.
Now, he's sharing his story – and his data – to bring that hope to other patients. 

🍁  Full story ▶ bit.ly/47Vmw4U